Effect of Thromboxane Synthetase lnhibition on Platelet Function and Morphology During Ovine Pregnancy-Induced Hypertension

Summary

Arterial blood pressure, serum fibrir/fibrinogen degratory products, plasma thromboxane B₂, in vitro platelet aggregation, and platelet ultrastructure were studied in ten gravid ewes during fast-triggered ovine pregnancy-induced hypertension and subsequent administration of the thromboxane synthetase inhibitors CGS13080 and CGS12970. During the hypertensive period, blood pressure (p <0.005) and plasma thromboxane B₂ levels (p <0.005) were significantly altered. Collagen-induced in vitro platelet aggregation lag times increased (p <0.01), and percent aggregation (p <0.05), primary (p <0.01), and secondary (p <0.005) aggregatory slopes decreased. Collagen also failed to induce aggregation in some ewes. Primary slopes of ADP-induced in vitro platelet aggregation decreased (p <0.01) during hypertension. Degranulation and open canalicular tubule system swelling were observed in platelets which produced abnormal or no aggregation response. However, these ultrastructural abnormalities did not necessarily correspond to hypertensive periods.

Thromboxane synthetase inhibitor administration lowered blood pressure (p <0.005) and plasma thromboxane B₂ levels (p <0.005). Abnormalities in collagen and ADP-induced platelet aggregation curves were also corrected, and ultrastructural abnormalities were not detected. Marked elevations in plasma thromboxane levels during ovine pregnancy-induced hypertension may have had an “exhaustive” effect on thrombocytes which was reversed by thromboxane synthetase inhibition.

Keywords

Thromboxane - Platelet aggregation - Pregnancy-induced hypertension - Platelet ultrastructure - Ovine pregnancy toxemia

• References

• 1 Ramon de Alvarez R. Current Obstetric and Gynecologic Diagnostics and Treatment. 5th. Edition Lange Medical Publications; Los Altos, CA: 1984: 763
• 2 Tiffany ML. Technical considerations for platelet aggregation and related problems. Crit Rev Clin Lab Sci 1983; 119: 27-69
• 3 Wierda A, Verhoeff J, van Dÿk S, Donesteÿn J, Wensing T. Effects of trenbolone acetate and propylene glycol on pregnancy toxemia in ewes. Vet Rec 1985; 116: 284-287
• 4 Thatcher CD, Keith JC. Pregnancy-induced hypertension: Development of a model in the pregnant sheep. Am J Obstet Gynecol 1986; 155: 201-207
• 5 Keith JC, Thatcher CD, Schaub RG. Beneficial effects of U63, 557A, a thromboxane synthetase inhibitor, in an ovine model of Pregnancy-Induced Hypertension. Am J Obstet Gynecol 1987; 157: 199-203
• 6 MacNab MW, Foltz EL, Graves BS. et al. The effects of a new thromboxane synthetase inhibitor, CGS13080, in man. J Clin Pharmacol 1984; 24: 76-83
• 7 Butler KD, Butler PA, Shand RA. et al. Prolongation of platelet survival in hypercholesterolaemic rabbits by CGS12970 (3-methyl-2-[3-pyridyl]-1 indoleoctanoic acid) and dazoxiben. Thromb Res 1987; 45: 751-761
• 8 Born GV R. Aggregation of blood platelets and its reversal. Nature 1962; 194: 927-929
• 9 White JG. The ultrastructure and regulatory mechanisms of blood platelets. In: Blood Platelet Function and Medicinal Chemistry Lasslo A. (ed). Elsevier Biomedical Publishers; New York: 1984: 15-59
• 10 Myers A, Shio H, Nicosia S, Ramwell PW. Platelet eicosanoid receptors. In: The Platelets: Physiology and Pharmacology Longenecker GL. (ed). Academic Press; Orlando. FL: 1985: 201
• 11 Howie PW. The haemostatic mechanisms of preeclampsia. Clin Obstet Gynaecol 1977; 4: 595-609
• 12 Wu KK, LeBreton GC, Jai HH, Chen YC. Abnormal platelet response to thromboxane A₂ . J Clin Invest 1981; 67: 1801-1804
• 13 Zawilska KM, Born GV R, Begent NA. Effect of ADP-utilizing enzymes on the arterial bleeding time in rats and rabbits. Br J Haematol 1982; 50: 317-325
• 14 Mais DE, Saussy DL, Chaikhouni A, Kochel PJ, Knapp DR, Hamanaka N, Halushka PV. Pharmacologic characterization of human and canine thromboxane A₂ prostaglandin H₂ receptors in platelets and blood vessels: evidence for different receptors. J Pharmacol Exp Ther 1985; 233: 418-424
• 15 Hirsh J, Castelan DJ, Loder PB. Spontaneous bruising associated with a defect in the interaction of platelets and connective tissue. Lancet 1967; 2: 18-21
• 16 Caen J, LeGrand Y. Abnormalities in the platelet collagen reaction. Ann NY Acad Sci 1972; 201: 194-204
• 17 Mielke CH, Rodvien R. Qualitative platelet abnormality due to absent collagen-induced aggregation. Thromb Haemostas 1976; 36: 283-285
• 18 Tiffany ML, Penner JA. Effect of complement on collagen-induced platelet aggregation. J Lab Clin Med 1980; 96: 796-802
• 19 Samuels P, Main EK, Tomaski A, Mennuti T, Gabbe SG, Clines DB. Abnormalities in platelet antiglobulin tests in preeclamptic mothers and their neonates. Am J Obstet Gynecol 1987; 157: 109-113
• 20 Rekonen F, Rosi V, Ammala M, Viinikka L, Ylikorkala O. Platelet function and coagulation in normal and preeclamptic pregnancy. Thromb Res 1986; 43: 553-560
• 21 Borok Z, Weitz J, Owen J, Auerbach M, Nossel HL. Fibrinogen proteolysis and platelet alpha-granule release in preeclampsia/eclampsia. Blood 1984; 63: 525-531
• 22 Wallenburg HC S, Rotmans N. Enhanced reactivity of the platelet thromboxane pathway in normotensive and hypertensive pregnancies with insufficient fetal growth. Am J Obstet 1982; 144: 523-528
• 23 Redman CW G, Bonner J, Beilin L. Early platelet consumption in pre-eclampsia. Br Med J 1978; 1: 467-469
• 24 Wallenburg HC, Rotmans N. Prevention of recurrent idiopathic fetal growth retardation by low-dose aspirin and dipyridamole. Am J Obstet Gynecol 1987; 157 (05) 1230-1235